Volver a Agenda
Session Chair(s)
Kim Quaintance-Lunn
Vice President, Head of Regulatory Science and Execution
Alexion, United States
Learning Objective : Recognize when formal dispute resolution is a viable option for a drug development program; Describe how to successfully navigate the formal dispute resolution process; Identify positive outcomes of the formal dispute resolution process.
Speaker(s)
We Disagree: Is Formal Dispute Resolution an Option?
Kim Quaintance-Lunn
Alexion, United States
Vice President, Head of Regulatory Science and Execution
Strategy for Discussing Formal Dispute Resolution
Josephine Torrente, JD, MS
Hyman, Phelps & McNamara, P.C., United States
Attorney
¿Tiene una cuenta?